Skin pigment battle: which melasma treatment wins?
NCT ID NCT07604844
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two treatments for melasma, a skin condition causing dark patches on the face. One group gets injections of tranexamic acid, the other gets mandelic acid chemical peels. Researchers will track pigmentation improvement and quality of life in 120 adults over several sessions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tranexamic acid and mandelic acid
- What this could lead to
- If successful, this study could show which treatment is more effective for reducing melasma pigmentation in South Asian skin types.
- What could go wrong
- This is a small, early-stage trial with no phase designation, so results may not apply broadly. Both treatments are cosmetic and not a cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELASMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Combined Military Hospital, Abbottabad
Abbottabad, KPK, 22010, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple pill make melasma creams work better?
- Can a two-acid cream fade stubborn melasma?
- Can sunscreen do more than protect? study tests if it fades dark spots
- New cream trio aims to outshine standard melasma treatment
- Can sound waves clear up skin? new trial tests ultrasound for pigment and rosacea
- New serums take on hydroquinone in skin brightening showdown